z-logo
open-access-imgOpen Access
Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory
Author(s) -
J-D Studt,
Valentina Bianchi,
Hans-Joachim Kremer
Publication year - 2003
Publication title -
schweizerische medizinische wochenschrift
Language(s) - English
Resource type - Journals
ISSN - 0036-7672
DOI - 10.4414/smw.2003.10242
Subject(s) - medicine , thrombotic thrombocytopenic purpura , adamts , microangiopathic hemolytic anemia , von willebrand factor , gastroenterology , schistocyte , adamts13 , thrombotic microangiopathy , immunology , platelet , disease , metalloproteinase , thrombospondin , matrix metalloproteinase
Severe deficiency of von Willebrand factor-cleaving protease (ADAMTS-13) activity (<5% of normal) is specific for classical thrombotic thrombocytopenic purpura (TTP), a disorder presenting with thrombocytopenia, microangiopathic haemolytic anaemia and often with organ dysfunction such as neurological symptoms, renal failure, and fever. A certain, though according to several case series, variable percentage of patients with clinically diagnosed TTP and most patients with other forms of thrombotic icroangiopathies (TMA) do not show severe ADAMTS-13 deficiency.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom